USANA Health Sciences Inc (USNA)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 856,858 | 923,915 | 1,001,720 | 1,190,170 | 1,137,750 |
| Receivables | US$ in thousands | 8,223 | 7,201 | 7,213 | 7,163 | 7,420 |
| Receivables turnover | 104.20 | 128.30 | 138.88 | 166.16 | 153.34 |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $856,858K ÷ $8,223K
= 104.20
The receivables turnover ratio measures how efficiently a company is able to collect cash from its customers. A higher receivables turnover indicates that the company is collecting payments from its customers more quickly.
For USANA Health Sciences Inc, the trend in the receivables turnover ratio from December 31, 2020, to December 31, 2024, shows a mixed performance. The ratio has generally fluctuated during this period, starting at 153.34 in 2020 and increasing to 166.16 in 2021. However, the ratio then decreased to 138.88 in 2022 and further dropped to 128.30 in 2023. The latest data point shows a relatively lower receivables turnover of 104.20 in 2024.
The decreasing trend in the receivables turnover ratio over the past few years may indicate that USANA Health Sciences Inc is facing challenges in collecting payments from its customers efficiently. This could potentially signal issues such as extending longer credit terms to customers or difficulties in collecting outstanding receivables.
It is important for the company to closely monitor its receivables turnover ratio and implement strategies to improve its collection processes in order to maintain healthy cash flows and working capital management.